# FDA 483 - Revive Rx LLC dba Revive Rx Pharmacy - May 04, 2022

Source: https://www.keypedia.com/records/483/revive-rx-llc-dba-revive-rx-pharmacy/bb06d0e8-f0b5-43d6-886b-0b17e9425dd3

> FDA 483 for Revive Rx LLC dba Revive Rx Pharmacy on May 04, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Revive Rx LLC dba Revive Rx Pharmacy
- Inspection Date: 2022-05-04
- Product Type: Drugs
- Office Name: Dallas District Office
- Summary: An FDA Form 483 was issued following an inspection, identifying multiple deficiencies in aseptic processing and facility controls.

Observations included personnel blocking first-pass air during aseptic manipulations. Specifically, on April 26, 2022, a pharmacy technician was observed reaching over open vials of "(b)(4) Sterile Solution for Injection, Lot #(b)(4)," leading to the disposal of the lot. On April 19, 2022, a technician used poor aseptic techniques when connecting a syringe to tubing for "(b)(4) Lot #(b)(4)," and both the PIC and technician failed to disinfect sterile gloves before returning components to the ISO 5 BSC, resulting in the disposal of this lot as well.

The firm failed to use sterile pharmaceutical-grade (b)(4) during sterile drug product processing, instead using a (b)(4) for "Dexamethasone 24 mg/ml Sterile Solution pH 7." Two lots, #585669 and #668512, remain within expiry with six patient prescriptions dispensed.

Inadequate HEPA filter coverage and airflow were noted, with the (b)(4) Systems lacking sufficient HEPA filters to maintain an ISO 5 environment from the BSC to the (b)(4) and crimping station, a repeat observation. (b)(4) integrity testing for the Sterile (b)(4) was not adequately performed or recorded. On

## Related Documents

- [483 - 2021-08-06](https://www.keypedia.com/records/483/revive-rx-llc-dba-revive-rx-pharmacy/b71db01e-8fd5-4bbe-ba98-e9b601e91269)
- [483 - 2022-05-04](https://www.keypedia.com/records/483/revive-rx-llc-dba-revive-rx-pharmacy/d62df77c-3e9d-4646-afd0-17c80f817623)
- [UNTITLED_LETTER - 2023-06-30](https://www.keypedia.com/records/untitled_letter/revive-rx-llc-dba-revive-rx-pharmacy/6f831744-0c44-4700-8543-503a45e9aeaf)
- [483 - 2025-02-07](https://www.keypedia.com/records/483/revive-rx-llc-dba-revive-rx-pharmacy/8c14d757-1587-4a97-adf0-66ee7be7d31a)
- [WARNING_LETTER - 2025-02-07](https://www.keypedia.com/records/warning_letter/revive-rx-llc-dba-revive-rx-pharmacy/95af4bc5-dbe9-4cf0-9f12-326c692062d0)

## Related Officers

- [Microbiologist](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/revive-rx-llc-dba-revive-rx-pharmacy/76ca0e11-cf06-411e-a944-bb16f40464d4

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
